Sharemaestro Newsreel

BioLife Solutions (NASDAQ: BLFS) shares Repligen merger video with staff

BioLife Solutions (NASDAQ: BLFS) has informed its employees about its pending merger with Repligen Corporation, distributing an internal email with a video from Repligen's CEO. The video introduces Repligen and discusses the anticipated benefits of the combination, particularly growth opportunities in the cell therapy …

Form 4 AtriCure Inc For: 3 August By Investing.com

This article reports on a Form 4 filing for AtriCure Inc. (ATRC) on August 3rd. It is a brief, factual announcement from Investing.com, providing no additional details or analysis beyond the filing date and company. The article also includes various market data and related …

Kestra Medical Technologies (KMTS) insider schedules 2,380-share stock sale after award vesting

Kestra Medical Technologies (KMTS) has reported that an insider plans to sell 2,380 shares of common stock through Merrill Lynch on August 3, 2026, with an estimated aggregate market value of $56,551.44. These shares were obtained from performance share unit awards that vested on …

Kestra Medical (KMTS) insider files to sell 7,590 common shares

An insider at Kestra Medical Technologies, Ltd. (KMTS), Traci Umberger, has filed to sell 7,590 shares of common stock under Rule 144, valued at approximately $181,061.84. The planned sale will be executed through Merrill Lynch on or after August 3, 2026, and is related …

Kestra Medical Technologies (KMTS) insider plans 5,391-share stock sale after awards vest

Kestra Medical Technologies (KMTS) has reported a planned sale of 5,391 shares of common stock with an indicated value of $128,312.27, scheduled for August 3, 2026, through Merrill Lynch on NASDAQ. These shares are related to performance share unit awards that vested on July …

APTARGROUP, INC. SEC Filing (Aug 3, 2026)

This SEC filing for AptarGroup, Inc. (ATR) is a Form 144 Notice of Proposed Sale of Securities. The filing indicates a sale of 9,838 shares of common stock with an aggregate market value of $1,339,588.32, acquired through the exercise of options under a registered …

Citi Initiates West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $412

Citi has initiated coverage on West Pharmaceutical Services (WST.US) with a Buy rating. The firm has set a price target of $412 for the company's stock. This initiation suggests a positive outlook from Citi on West Pharmaceutical Services' future performance.

Bank of Nova Scotia Has $1.95 Million Stake in The Cooper Companies, Inc. $COO

Bank of Nova Scotia significantly reduced its stake in The Cooper Companies by 88.2% in the first quarter, selling over 200,000 shares but still retaining shares worth approximately $1.95 million. Despite this, other major institutional investors increased their holdings, with institutional ownership collectively at …

Intuitive Surgical Inc Stock (ISRG) Moved Up by 5.70% on Aug 3: Facts Behind the Movement

Intuitive Surgical Inc (ISRG) saw its stock price increase by 5.70% due to a significant beat in quarterly procedure volume growth, robust recovery in elective surgeries, and strong adoption of its robotic platforms and AI integration. The company's financial stability, technological leadership, and positive …

Solventum Corp. stock rises Monday, outperforms market

Solventum Corp. (SOLV) shares increased by 3.08% on Monday, closing at $88.07. This rise occurred during a generally positive trading session, where the S&P 500 Index gained 1.48% and the Dow Jones Industrial Average rose 1.32%, marking the end of a two-day losing streak …

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

Shares of West Pharmaceutical Services Inc. (WST) increased by 2.05% to $347.94, outperforming its competitors on a strong trading day. The company's stock experienced its sixth consecutive day of gains, while the broader S&P 500 Index and Dow Jones Industrial Average also saw significant …

Becton Dickinson & Co. stock outperforms competitors on strong trading day

Becton Dickinson & Co. (BDX) stock rose 2.77% to $170.21 on Monday, outperforming the broader market which also saw significant gains. This marks the second consecutive day of gains for the stock. The S&P 500 and Dow Jones Industrial Average also experienced strong trading …

Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Sanara MedTech Inc. (SMTI) to MiMedx Group, Inc. (MDXG). KSF is examining whether the offered consideration of $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share undervalues the …

Price to book forward of Femasys Inc. – NASDAQ:FEMY

This article provides a brief snapshot of Femasys Inc. (NASDAQ: FEMY) on TradingView, specifically focusing on its forward price-to-book ratio. The content indicates that the market was closed at the time of viewing, with no trades observed. It also lists various data sources and …

Solventum to Report Q2 Earnings: What's in Store for the Stock?

Solventum (SOLV) is expected to report its second-quarter 2026 earnings on August 5th. Analysts project revenues of $2.17 billion and earnings of $1.91 per share, driven by strength in its MedSurg, Dental, and Health Information Systems segments, as well as the Acera acquisition and …

First Trust Advisors LP Sells 32,742 Shares of The Cooper Companies, Inc. $COO

First Trust Advisors LP reduced its stake in The Cooper Companies (NASDAQ:COO) by 21.4% in the first quarter, selling 32,742 shares and retaining 120,148 shares valued at approximately $8.6 million. The medical device company reported strong quarterly earnings of $1.21 per share, beating estimates, …

How FDA Approval of First Freeze Dried Plasma Platform Will Impact Teleflex (TFX) Investors

Teleflex (TFX) recently received FDA approval for EZPLAZ Freeze Dried Plasma, the first FDA-licensed freeze-dried plasma for adult transfusions, which could reshape its investment narrative. This approval, alongside other innovations like the BIOMAG III trial, signifies Teleflex's shift towards differentiated, higher-value medical devices. However, …

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP is reminding investors of Embecta Corp. (EMBC) about an upcoming August 17, 2026 deadline to file a lead plaintiff motion in a class action lawsuit. The lawsuit alleges that Embecta made materially false and misleading statements between November …

Pulse Biosciences stock hits 52-week high at 36.79 USD By Investing.com

Pulse Biosciences Inc. (PLSE) stock hit a new 52-week high of $36.79, reflecting a 138% return over the past year and 156% year-to-date gains. Despite this performance, InvestingPro analysis suggests the stock might be overvalued, noting high volatility and unlikelihood of profitability this year. …

Investors brace for Stevanato earnings amid GLP-1 packaging surge By Investing.com

Stevanato Group SpA is set to report its second-quarter earnings, with analysts expecting significant year-over-year growth in EPS and revenue. Investors are keenly watching the company's ability to leverage the booming GLP-1 obesity drug market and the broader biologics expansion, focusing on its shift …

Trading the Move, Not the Narrative: (WRBY) Edition

This article provides an AI-generated analysis for Warby Parker Inc. Class A (NASDAQ: WRBY), highlighting divergent sentiment readings and a mid-channel oscillation pattern. It outlines three distinct trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) tailored for different risk profiles, along with multi-timeframe …

H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $21

H.C. Wainwright has reiterated its Buy rating for Bausch + Lomb Corp. (BLCO.US) and increased the price target to $21. This indicates a positive outlook from the analyst firm regarding the company's future stock performance.

EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

The Rosen Law Firm reminds investors who purchased Embecta Corp. (NASDAQ: EMBC) common stock between November 25, 2025, and May 4, 2026, of the upcoming August 17, 2026 lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Embecta made misleading statements …

AtriCure, Inc. (ATRC) CEO makes 4,700-share stock gifts to family, charity

Michael H. Carrel, CEO of AtriCure, Inc. (ATRC), reported bona fide gifts of 4,700 shares of common stock on July 30, 2026. These gifts included 700 shares to a parent and 4,000 shares to a charity, all without consideration. The filing also details his …

Kaplan Fox is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (MDLN) for potential securities law violations following a warning letter from the FDA. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and "inadequate cleaning practices," which led to a 7.16% drop in …

Intuitive Surgical Stock (ISRG) Opinions on Recent Quarterly Results

This article provides investor opinions on Intuitive Surgical (ISRG) stock following its recent quarterly results. It likely discusses whether the results met expectations, key performance indicators, and how these factors might influence the stock's future trajectory.

Segall Bryant & Hamill LLC Buys 16,644 Shares of AptarGroup, Inc. $ATR

Segall Bryant & Hamill LLC increased its stake in AptarGroup, Inc. by 20.6% in the first quarter, purchasing 16,644 additional shares to own a total of 97,624 shares valued at approximately $12.3 million. This increase contributes to the 88.52% institutional ownership of the company. …

Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Its 9.65% Potential Upside

Bausch + Lomb Corporation (BLCO), an eye health leader with a $6.04 billion market cap, shows a 9.65% potential upside despite a negative EPS and ROI. The company's robust revenue growth of 9.10% across its Vision Care, Pharmaceuticals, and Surgical segments, along with a …

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 32.3% Revenue Growth Amidst a Complex Valuation

CMR Surgical Banks On Portability And Open Data To Crack Da Vinci-Dominated Market

CMR Surgical is challenging Intuitive Surgical's dominance in the robotic surgery market by

POCI|Precision Optics Corporation Inc|Price:4.250|Chg%:+0.010

Kestra Medical Technologies CEO sells $692k in shares

Kestra Medical Technologies, Ltd.'s President and CEO, Brian Daniel Webster, sold 51,900 common shares of KMTS on August 4, 2026, across three transactions. These "sell to cover" sales were nondiscretionary and executed to satisfy tax withholding obligations related to the vesting of restricted stock …

Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 13,015 Shares of Stock

Kestra Medical Technologies (KMTS) has disclosed a planned sale of 13,015 shares of common stock through Merrill Lynch on or about July 31, 2026, stemming from vested performance share unit awards. The aggregate market value of this planned sale is approximately $311,118.83. Additionally, an …

Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention

How Utah Medical Products Inc. (UTMD) Affects Rotational Strategy Timing

This article from Stock Traders Daily analyzes Utah Medical Products Inc. (UTMD) and its impact on rotational strategy timing. It highlights a near-term strong sentiment possibly influencing mid-term neutrality and a long-term positive bias, noting a mid-channel oscillation pattern. The analysis provides specific institutional …

Anteris Technologies Global Corp Discloses Lapse of 46,417 Restricted Stock Units and Options

Anteris Technologies Global Corp (ASX:AVR) announced the cessation of 46,417 unquoted equity securities, including restricted stock units (RSUs) and options, due to the lapse of conditional rights in July 2026. The lapse occurred because conditions for these securities were not met, and no consideration …